Abrdn Healthcare Investors
Price Action
Technical Summary
STAGE 2 UPTRENDAbrdn Healthcare Investors is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is moderate (RS Rating: 68), indicating performance broadly in line with the market. Earnings growth of 400% provides fundamental context to the price action. Momentum will need to be maintained above the 50-day moving average to sustain this leadership phase.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $19.74 | +9.58% | ABOVE |
| 50 SMA | $19.77 | +9.42% | ABOVE |
| 100 SMA | $19.28 | +12.20% | ABOVE |
| 150 SMA | $19.21 | +12.60% | ABOVE |
| 200 SMA | $18.98 | +13.99% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is HQH in an uptrend right now?
HQH has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, HQH is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is HQH overbought or oversold?
HQH's RSI (14) is 73. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is HQH outperforming the market?
HQH has a Relative Strength (RS) Rating of 68 out of 99. HQH is performing about average compared to the market.
Where is HQH in its 52-week range?
HQH is trading at $21.63, which is 99% of its 52-week high ($21.84) and 97% above its 52-week low ($15.46).
How volatile is HQH?
HQH has a Beta of 0.68 and 52-week volatility of 21%. It's less volatile than the S&P 500 - generally more stable.